Could a common heart drug stop pneumonia after a stroke?
NCT ID NCT07528235
First seen Apr 26, 2026 · Last updated Apr 29, 2026 · Updated 2 times
Summary
This study tests whether a 7-day continuous IV drip of propranolol (a drug usually used for heart conditions) can safely prevent pneumonia in people who have had a severe brain bleed (intracerebral hemorrhage). The trial will enroll 30 adults and aims to find the best dose while checking for side effects. It is an early-stage, open-label study, meaning everyone knows they are getting the drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRACEREBRAL HEMORRHAGE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Neurosurgery , Tangdu Hospital, Fourth Military Medical University
Xi'an, Shaanxi, 710038, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.